Silence Therapeutics, Plc.

The current price of SLNCF is 8.00 USD — it hasn't changed in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Silence Therapeutics, Plc. stocks are traded under the ticker SLNCF.

Silence Therapeutics, Plc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.

SLNCF stock is 0% volatile and has beta coefficient of 0.49. Check out the list of the most volatile stocks — is Silence Therapeutics, Plc. there?

SLNCF earnings for the last quarter are −0.03 USD per share, whereas the estimation was −0.06 USD resulting in a 46.41% surprise. The estimated earnings for the next quarter are −0.03 USD per share. See more details about Silence Therapeutics, Plc. earnings.

Silence Therapeutics, Plc. revenue for the last quarter amounts to ‪3.41 M‬ USD despite the estimated figure of ‪2.93 M‬ USD. In the next quarter revenue is expected to reach ‪8.95 M‬ USD.

Yes, you can track Silence Therapeutics, Plc. financials in yearly and quarterly reports right on TradingView.

SLNCF net income for the last quarter is ‪−18.35 M‬ USD, while the quarter before that showed ‪−10.06 M‬ USD of net income which accounts for −82.32% change. Track more Silence Therapeutics, Plc. financial stats to get the full picture.

No, SLNCF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, SLNCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Silence Therapeutics, Plc. stock right from TradingView charts — choose your broker and connect to your account.

SLNCF reached its all-time high on Apr 25, 2022 with the price of 46.50 USD, and its all-time low was 0.01 USD and was reached on Jul 5, 2012.
See other stocks reaching their highest and lowest prices.

As of Apr 28, 2024, the company has 109.00 employees. See our rating of the largest employees — is Silence Therapeutics, Plc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Silence Therapeutics, Plc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Silence Therapeutics, Plc. stock shows the strong buy signal. See more of Silence Therapeutics, Plc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Silence Therapeutics, Plc. future price: according to them, SLNCF price has a max estimate of 24.16 USD and a min estimate of 13.59 USD. Read a more detailed Silence Therapeutics, Plc. forecast: see what analysts think of Silence Therapeutics, Plc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Silence Therapeutics, Plc. EBITDA is ‪−62.51 M‬ USD, and current EBITDA margin is −193.52%. See more stats in Silence Therapeutics, Plc. financial statements.